Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia
Platelet hyperactivation is involved in the established prothrombotic condition of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM) and familial hypercholesterolemia (HC), justifying the therapy with aspirin, a suppressor of thromboxane synthesis through the irreversible inhibition of cycl...
Main Authors: | Cristina Barale, Franco Cavalot, Chiara Frascaroli, Katia Bonomo, Alessandro Morotti, Angelo Guerrasio, Isabella Russo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/14/4983 |
Similar Items
-
Impaired Clinical Efficacy of Aspirin in Hypoalbuminemic Patients With Diabetes Mellitus
by: Angela Sciacqua, et al.
Published: (2021-06-01) -
Lower Antiplatelet Effect of Aspirin in Essential Thrombocythemia than in Coronary Artery Disease
by: Oliver Buchhave Pedersen, et al.
Published: (2021-07-01) -
Effect of madecassoside combined with aspirin on platelet functions
by: Theiarawat Kraikate, et al.
Published: (2015-09-01) -
Superoxide Dismutases in Pancreatic Cancer
by: Justin G. Wilkes, et al.
Published: (2017-08-01) -
Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?
by: Francesco Taus, et al.
Published: (2019-11-01)